π The national vaccination campaign recommends immunisation in adults over 70 to prevent shingles and postherpetic neuralgia.
ποΈ Also see related topics on Herpes Zoster Ophthalmicus and Varicella (chickenpox).
π About
- π¬ Herpes viruses are double-stranded DNA viruses.
- π¬οΈ Spread by droplet transmission β highly contagious.
- π§ Most people gain immunity in childhood, but virus may reactivate later in life β shingles.
- π― Targets the skin, eyes, and nervous system.
π¦ Virology
- Varicella β chickenpox; Zoster β shingles.
- β³ Incubation: 10β21 days.
- π§ Virus remains latent in dorsal root ganglia or cranial nerve nuclei.
π©Ή Shingles
Characteristic belt-like rash, unilateral, confined to a single dermatome.
β οΈ Severe, extensive, or prolonged disease should raise suspicion for immunosuppression (e.g., HIV).
π Chickenpox can be caught from shingles, but not the other way around.
π©Ί Clinical Presentation
- π₯ Sharp, burning pain precedes rash (typically 2β3 days).
- π‘οΈ Fever, malaise, itching, tingling.
- π©Ή Rash: grouped vesicles on erythematous base, confined to dermatome.
- πΆ Children: chickenpox β crops of vesicular lesions + fever.
- π¨ Adults: higher morbidity/mortality (15Γ that of children).
- π€° Pregnancy: risk of varicella pneumonitis.
- π§ Complications: pneumonitis, encephalitis (20% fatality), hepatitis, thrombocytopenia.
π Other Manifestations
- β‘ Postherpetic neuralgia: persistent neuropathic pain.
- ποΈ Herpes Zoster Ophthalmicus: corneal involvement (ophthalmic branch of CN V).
- π Ramsay Hunt syndrome: facial palsy + vesicles in ear canal.
- π§ Neurological: transverse myelitis, Guillain-BarrΓ© syndrome, stroke syndromes (zoster vasculitis).
π¬ Risks for Varicella Pneumonia
- Smoking
- Pregnancy
- Immunosuppression
- Male sex
π§ββοΈ Immunocompromised Patients
- π₯ More severe, widespread, or prolonged disease.
- High-risk groups: HIV (low CD4), transplant recipients, patients on steroids/azathioprine/TNF antagonists, malignancy, pregnancy.
π§ͺ Investigations
- π©Έ Baseline bloods: FBC, U&E, LFT, CRP.
- π§« Vesicle fluid: PCR, EM, fluorescent antibody test.
- π Assess for immunodeficiency or cancer red flags.
π οΈ Primary Care Management
- π Start oral antiviral within 72 h: e.g., Aciclovir 800 mg 5Γ daily Γ 7 days.
- π‘ Provide analgesia: paracetamol Β± codeine; consider amitriptyline/gabapentin if neuropathic pain.
- π Keep rash covered; avoid contact with non-immune, pregnant, or immunocompromised individuals until crusted over.
- π£οΈ Reassure: usually self-limiting but risk of postherpetic neuralgia.
- π
Follow-up if pain >4 weeks or rash becomes widespread (screen for immunosuppression).
- π Discuss zoster vaccination for future prevention (if not already given).
π₯ Hospital Management
- πͺ Isolate; only immune staff should provide care.
- π Antivirals (start β€72h of rash):
- Aciclovir 800 mg 5Γ daily Γ 7 days
- Famciclovir 500 mg tds Γ 7 days
- Valaciclovir 1 g tds Γ 7 days
- π§ββοΈ Immunocompromised: same drugs but longer course (continue 2 days post-crusting).
- π Pain relief: paracetamol, codeine Β± neuropathic agents.
- π©ββοΈ Pregnant/breastfeeding: consult microbiology before antivirals.
β‘ Postherpetic Neuralgia
- Chronic neuropathic pain after shingles.
- β¬οΈ Risk with age and severe acute pain.
- Options: amitriptyline, gabapentin, duloxetine, topical capsaicin, lidocaine patches.
- Tramadol: short-term rescue only (avoid long-term).
π‘οΈ Prevention
- π National shingles vaccine β₯70 yrs to reduce incidence and neuralgia.
- π©βπΌ Exposed non-immune pregnant/immunocompromised β Zoster Immunoglobulin (ZIG) within 10 days.
- π If infection develops β treat with aciclovir; seek microbiology advice.
π References